```html

Yellow‑green Algae Exposure (Cyanobacterial Bloom Toxicity)

Overview

Cyanobacteria—commonly called “blue‑green algae” or “yellow‑green algae”—are microscopic, photosynthetic bacteria that thrive in fresh and brackish water when nutrients (especially phosphorus and nitrogen) are abundant and water temperature is warm (typically >20 °C/68 °F). Under favorable conditions they can multiply rapidly, forming dense colonies known as cyanobacterial blooms. Some species produce potent toxins (microcystins, cylindrospermopsin, anatoxin‑a, saxitoxin, and others) that can affect humans, pets, livestock, and wildlife.

Who it affects: Anyone who drinks contaminated water, swims in or splashes water during a bloom, engages in water‑sports, or ingests fish, shellfish, or plants exposed to toxins. Children, the elderly, and people with liver or kidney disease are especially vulnerable.

Prevalence: In the United States, cyanobacterial blooms have been reported in >60 % of surveyed lakes and reservoirs, with a sharp increase over the past two decades due to climate change and nutrient runoff (EPA, 2023). Globally, >400,000 water bodies are estimated to experience harmful blooms each year.<sup>[1]</sup>

Symptoms

Symptoms vary with the type of toxin, the route of exposure (ingestion, skin contact, inhalation), and individual susceptibility. Below is a comprehensive list:

Gastrointestinal exposure (drinking or swallowing water)

• Nausea & vomiting – typically within 30 minutes to 6 hours after ingestion.
• Abdominal cramping – diffuse or localized pain.
• Diarrhea – may be watery or bloody in severe cases.
• Loss of appetite – often accompanies nausea.

Hepatotoxic (liver) toxins – mainly microcystins

• Elevated liver enzymes (ALT, AST) – detectable on blood tests.
• Jaundice – yellowing of the skin and eyes.
• Right‑upper‑quadrant abdominal pain – due to liver inflammation.
• Fatigue & malaise – may persist for days.

Neurotoxic toxins – anatoxin‑a, saxitoxin, cylindrospermopsin

• Headache – often described as throbbing.
• Dizziness or vertigo
• Muscle weakness or twitching
• Para‑ or tetraparesis – severe cases can lead to paralysis.
• Confusion, seizures, or loss of consciousness.
• Respiratory distress – especially with anatoxin‑a (a potent nicotinic acetylcholine receptor agonist).

Dermatologic and ocular exposure (skin contact, splashing, inhaling aerosols)

• Skin irritation – redness, itching, or a burning sensation.
• Rash or dermatitis – may develop hours after contact.
• Conjunctivitis – red, watery eyes.
• Respiratory irritation – cough, throat soreness when aerosols are inhaled.

Systemic signs (any route)

• Fever (rare, but can occur with systemic inflammation).
• Rapid heart rate (tachycardia).
• Low blood pressure (hypotension) in severe poisoning.

Causes and Risk Factors

Primary causes

• Harmful cyanobacterial bloom (HAB) – proliferation of toxin‑producing species such as Microcystis aeruginosa, Anabaena spp., Cylindrospermopsis raciborskii, and Ana‑cyanobacteria.
• Exposure pathways:
  • Drinking untreated surface water.
  • Swallowing water while swimming, kayaking, or rafting.
  • Skin contact during recreational activities.
  • Inhalation of aerosolized toxins from wave action or water‑fountains.
  • Consumption of contaminated fish, shellfish, or aquatic plants.

Risk factors

• Living near eutrophic lakes, ponds, or slow‑moving rivers.
• Recent heavy rainfall combined with warm temperatures (promotes nutrient runoff).
• Use of fertilizers or septic systems that release phosphorus/nitrogen.
• Recreational activities during visible green‑ish scums or foul‑smelling water.
• Pre‑existing liver disease, chronic kidney disease, or immunosuppression.
• Young children who are more likely to ingest water.

Diagnosis

Because cyanobacterial toxicity is relatively rare and symptoms can mimic other conditions, a high index of suspicion is essential.

Clinical assessment

• Detailed exposure history (location, date, activity, water appearance).
• Symptom chronology and severity.

Laboratory tests

• Blood chemistry – AST, ALT, alkaline phosphatase, bilirubin (liver injury); creatinine, BUN (renal function); electrolytes.
• Complete blood count (CBC) – may show leukocytosis in severe inflammation.
• Specific toxin assays – ELISA or LC‑MS/MS detection of microcystins, cylindrospermopsin, anatoxin‑a in serum, urine, or stool (available at specialized labs).
• Coagulation profile – some toxins affect clotting.

Imaging

• Abdominal ultrasound or CT if acute liver failure is suspected.

Environmental testing

• Water samples from the exposure site tested for cyanotoxin concentration (EPA Method 546.1). Public health agencies often provide alerts when levels exceed the WHO provisional guideline of 1 µg/L for microcystin‑LR.

Treatment Options

Management focuses on supportive care, toxin removal, and preventing organ damage.

Immediate steps

• Remove the source – get the patient out of the contaminated water, discard any contaminated water supplies.
• Decontamination – rinse skin and eyes with clean water for at least 15 minutes.

Gastrointestinal decontamination

• Activated charcoal (50 g for adults) within 1 hour of ingestion may bind some toxins.
• Whole‑bowel irrigation (lavage) in severe cases, performed by medical personnel.

Supportive medical therapy

• Intravenous fluids – maintain hydration and renal perfusion.
• Antiemetics – ondansetron or promethazine for nausea/vomiting.
• Liver‑protective agents – N‑acetylcysteine (NAC) has been used off‑label for microcystin‑induced hepatotoxicity (dose: 150 mg/kg loading, then 50 mg/kg 4 h, then 100 mg/kg 16 h).
• Renal support – diuretics or, if acute kidney injury develops, renal replacement therapy.
• Respiratory support – oxygen, intubation for severe neurotoxic respiratory paralysis.
• Seizure control – benzodiazepines (e.g., lorazepam) if convulsions occur.

Specific antidotes

No universally approved antidote exists for cyanobacterial toxins. Experimental therapies (e.g., monoclonal antibodies against microcystin) are in early clinical trials.

Follow‑up care

• Liver function tests weekly for 4–6 weeks after exposure.
• Renal function monitoring.
• Neurocognitive assessment if neurotoxic symptoms were present.

Living with Yellow‑green Algae Exposure (Cyanobacterial Bloom Toxicity)

Patients who have experienced a bloom exposure often worry about future incidents. Here are practical tips for daily life:

• Water source awareness: Know whether your community water is drawn from surface reservoirs prone to blooms. Request annual testing reports.
• Home filtration: Use NSF‑certified reverse‑osmosis or activated‑carbon filters that can remove microcystins (look for certifications against “cyanotoxins”).
• Personal hygiene: After swimming in a natural body of water, shower promptly, wash swimsuits in hot water, and avoid touching your face.
• Food safety: Do not harvest wild fish, shellfish, or aquatic plants from lakes with known blooms. Follow local advisories.
• Medication review: Some liver‑metabolized drugs (e.g., acetaminophen) may increase hepatic stress; discuss dosage adjustments with your provider.
• Symptom diary: Keep a log of any recurring abdominal, skin, or neurological symptoms—useful for follow‑up visits.
• Stay connected: Subscribe to local health department alerts (often via text or email) about bloom status.

Prevention

Prevention is a shared responsibility between individuals, communities, and policymakers.

• Avoid swimming or recreating in water that appears discolored, has scummy surfaces, or emits a strong earthy/rotten‑egg odor.
• Use posted warnings: Many parks post “No swimming – cyanobacteria bloom” signs.
• Protect drinking water: If you rely on a private well, have it tested for cyanotoxins when a bloom is reported nearby.
• Limit nutrient runoff:
  • Apply fertilizers judiciously (follow the “4‑R” – right source, rate, time, place).
  • Maintain riparian buffer zones of native vegetation.
  • Repair leaky septic systems promptly.
• Community actions:
  • Support local programs for lake aeration, phosphorus‑binding alum treatment, and watershed management.
  • Advocate for stricter agricultural nutrient regulations.

Complications

If exposure is not recognized or treated promptly, serious complications can develop:

• Acute liver failure – may require transplant; mortality up to 30 % in severe cases.<sup>[2]</sup>
• Acute kidney injury (AKI) – can progress to chronic kidney disease.
• Neurologic sequelae – persistent weakness, peripheral neuropathy, or cognitive deficits.
• Respiratory failure – especially with anatoxin‑a; may need mechanical ventilation.
• Secondary infections – due to compromised mucosal barriers.
• Pregnancy complications – limited data, but animal studies suggest potential teratogenic effects.

When to Seek Emergency Care

References

1. Environmental Protection Agency (EPA). “Cyanobacterial Harmful Algal Blooms.” 2023. https://www.epa.gov/cyanohabs
2. World Health Organization (WHO). “Guidelines for Cyanobacterial Toxins in Drinking‑Water.” 2022. https://www.who.int/publications/i/item/WHO-2022-cyanotoxins
3. Mayo Clinic. “Microcystin poisoning.” Updated 2024. https://www.mayoclinic.org/diseases-conditions/microcystin-poisoning
4. Cleveland Clinic. “Cyanobacterial (Blue‑Green Algae) Toxicity.” 2023. https://my.clevelandclinic.org/health/diseases/22458-cyanobacterial-toxicity
5. Centers for Disease Control and Prevention (CDC). “Harmful Algal Blooms.” 2024. https://www.cdc.gov/habs/index.html

```